Amol Pendse

404 total citations
8 papers, 253 citations indexed

About

Amol Pendse is a scholar working on Infectious Diseases, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amol Pendse has authored 8 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amol Pendse's work include COVID-19 Clinical Research Studies (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Treatment and Management (3 papers). Amol Pendse is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Treatment and Management (3 papers). Amol Pendse collaborates with scholars based in India, Canada and United Kingdom. Amol Pendse's co-authors include Monika Tandon, Hanmant Barkate, Zarir Udwadia, Cynthia Caracta, Saiprasad Patil, Pawan Singh, Rahul Kodgule, Keith Moore, Brij Mohan and Mala Dharmalingam and has published in prestigious journals such as Drugs, International Journal of Infectious Diseases and ERJ Open Research.

In The Last Decade

Amol Pendse

7 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amol Pendse India 5 162 66 54 38 34 8 253
Sajad Khiali Iran 9 177 1.1× 107 1.6× 62 1.1× 15 0.4× 32 0.9× 23 325
Zeba Siddiqi India 10 185 1.1× 29 0.4× 66 1.2× 32 0.8× 23 0.7× 31 394
Helen Tanner Australia 5 192 1.2× 80 1.2× 78 1.4× 15 0.4× 32 0.9× 8 324
Jiake Tang China 7 221 1.4× 69 1.0× 55 1.0× 44 1.2× 99 2.9× 22 407
Firas Almazedi United Kingdom 2 220 1.4× 31 0.5× 64 1.2× 47 1.2× 79 2.3× 2 335
Forough Heidarzad Iran 6 130 0.8× 55 0.8× 49 0.9× 24 0.6× 47 1.4× 7 230
Jarosław Przybyciński Poland 7 135 0.8× 42 0.6× 65 1.2× 10 0.3× 24 0.7× 13 294
Yi-Ping Yang Taiwan 5 190 1.2× 72 1.1× 37 0.7× 9 0.2× 26 0.8× 8 311
Amirhossein Hessami Iran 8 140 0.9× 63 1.0× 23 0.4× 12 0.3× 38 1.1× 16 265
Shengyu Zhang China 6 171 1.1× 101 1.5× 55 1.0× 10 0.3× 24 0.7× 9 284

Countries citing papers authored by Amol Pendse

Since Specialization
Citations

This map shows the geographic impact of Amol Pendse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol Pendse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol Pendse more than expected).

Fields of papers citing papers by Amol Pendse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol Pendse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol Pendse. The network helps show where Amol Pendse may publish in the future.

Co-authorship network of co-authors of Amol Pendse

This figure shows the co-authorship network connecting the top 25 collaborators of Amol Pendse. A scholar is included among the top collaborators of Amol Pendse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol Pendse. Amol Pendse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
3.
Tandon, Monika, Keith Moore, Stephen Winchester, et al.. (2022). SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial. The Lancet Regional Health - Southeast Asia. 3. 100036–100036. 23 indexed citations
4.
Patil, Saiprasad, et al.. (2022). Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting. International Journal of General Medicine. Volume 15. 4551–4563. 5 indexed citations
5.
6.
Salvi, Sundeep, Srikanth V. Krishnamurthy, Saiprasad Patil, et al.. (2021). Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial. ERJ Open Research. 7(3). 255–2021. 6 indexed citations
7.
Udwadia, Zarir, Pawan Singh, Hanmant Barkate, et al.. (2020). Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. International Journal of Infectious Diseases. 103. 62–71. 175 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sajad Khiali Breakdown of academic impact, for papers by Zeba Siddiqi Breakdown of academic impact, for papers by Helen Tanner Breakdown of academic impact, for papers by Jiake Tang Breakdown of academic impact, for papers by Firas Almazedi Breakdown of academic impact, for papers by Forough Heidarzad Breakdown of academic impact, for papers by Jarosław Przybyciński Breakdown of academic impact, for papers by Yi-Ping Yang Breakdown of academic impact, for papers by Amirhossein Hessami Breakdown of academic impact, for papers by Shengyu Zhang
Rankless by CCL
2026